To be effective in inhibiting R-factor transfer (between Escherichia coli strains) and infection of E. coli with phage f2, requinomycin must be present at the time of initiation of both events. Delayed addition of requinomycin showed no or slight inhibition.
No direct effect of requinomycin on phage f2
or E.coli strains employed was observed. The intact cell surface of E.coli must be impermeable to requinomycin as shown by the fact that DNA synthesis by toluene-treated E. coli cells (permeability modified) was markedly inhibited by requinomycin, in contrast to its ineffectiveness on intact E. coli cells.
Therefore, requinomycin probably acts without penetrating the cells.
Probable mechanism of action is discussed.
R-Factors which determine resistance to a wide range of antibiotics are transmitted between enteric bacteria by conjugation1^.
In a preceding paper we reported that a new anthracycline antibiotic requinomycin blocked R-factor transfer at concentrations which did not inhibit the growth of E. coli3). Since requinomycin had originally been screened for anti-phage activity, we became interested in learning if there is. some biological process(es) commonto both R-factor transfer and phage infection.
As we shall report in the present paper, it seems that requinomycin exerts these effects by binding reversibly to some component(s) of the cell surface.
Materials and Methods
Anti-phage activity : The time sensitivity to requinomycin was determined as follows : E. coli S-26 was grown in Polypeptone broth at 37°C under shaking until an O.D. of 0.18 at 600m/i was reached.
From the cell suspension, 1.7ml portions were distributed into small test tubes which were placed in a 37°C bath at minute "zero" and incubated under shaking. At minute 5, 10, 15, 20 or 30, one tube for each run received 0.2ml of 200jug/ ml of requinomycin solution (or 0.85 % NaCl solution for a control run), while at minute 10, each tube received 0.1ml suspension of phage f2 (108 pfu*). Incubation was terminated at minute 110 by chilling and the mixtures were serially diluted with 0.85 % NaCl-2 mM CaCl2. One-tenth ml portions of the diluted suspensions were titrated for pfu using E.coli S-26 as an indicator strain by the pour plate method. reported in a preceding paper, if requinomycin was added 10 minutes before infection at concentrations of 100 //g/ml, 10 jug/ml and 1 /*g/ml, it inhibited phage production "by 95 %, 85 % and 38 %, respectively, under similar conditions. It has been confirmed "by a separate experiment that requinomycin does not inhibit the growth of the host cells at concentrations as high as 100jug/ml. Does Requinomycin Inactivate Phage Particles? Even after a prolonged incubation of a phage suspension in the presence of 100 jug/ml of requinomycin, the phage titer of the solution, assayed after dilutions, was found unchanged as shown in Table 1 . This result ruled out the possibility that requinomycin inactivates phage particles. Therefore, if requinomycin has any direct effect on phage particles, the effect should be of reversible nature since it can be abolished upon dilution.
Inhibition of R-Factor Transfer
Time Sensitivity to Requinomycin In the preceding paper3) we reported that requinomycin inhibited R-factor transfer by 92%, 58% and 19 % at concentrations of 50/jg/ml, 25jugl'ml and 5jug/ml, respectively, if the antibiotic was present at the time of mixing of donor and recipient cells.
Under these conditions, requinomycin did not affect the viability of either donor or recipient cells. In the present experiment, the time of addition of requinomycin was varied during the course of R-factor transfer.
As shown in Fig. 2 , requinomycin was very effective only when it was present throughout the incubation period. Later additions of requinomycin showed lesser inhibition.
These results suggested that requmomycin inhibits the transfer process per se but has no effect on Runs were triplicated and averaged. The experiment was conducted as given under Materials and Methods. Under these conditions, 100//g/ml of requinomycin appeared somewhat growth-inhibitory to this strain of E.coli ; total cells in +requinomycin run were fewer than those in control run (4.1x108 vs.8.7x 108). This is in contrast to other observations that requinomycin showed no effect on the doubling time of any E.coli strain (based on turbidity measurement or cell counting) at a concentration as high as 100//g/ml. This inconsistency may be due to difference either in growth conditions or the period of drug treatment. However, the conclusion drawn from this experiment is not affected by this inconsistency because most cells (3.6x108 in 4.1x108) retained resistance to kanamycin after the treatment with requinomycin. Impermeability of E. coli Cell Surface to Requinomycin Inhibition by Requinomycin of DNASynthesis in Toluenized E. coli Cells Considering the ineffectiveness of requinomycin to any E. coli strain used for the present study, the simplest explanation for the requinomycin action would be that requinomycin binds to the cell surface in a specific manner to modify the function of sex-pilus or its receptor but not to interfere with membrane transport of essential metabolites.
At present, exact nature of the target molecule to which requinomycin binds is not known. However, it must localize on the cell surface because of the following observation.
As shown in Table 3 , requinomycin markedly inhibits DNA synthesis in toluenized E. coli cells in contrast to its ineffectiveness to intact cells.
Interaction with DNA template could be characteristic to anthracycline antibiotics7~9).
This result strongly suggests that the intact cell surface of E.coli is impermeable to requinomycin.
Discussion
Sex-pili are essential structures for both adsorption of phage f2 and conjugation10â nd therefore, sex-pili or their receptors are suspected to be the binding sites of requinomycin. However, it has been reported recently that levallorphan, a structural analogue of morphine, also inhibited both phage infection and R-factor transfer11>12) and the latter action was thought to be due to inhibition of mating pair formation. Requinomycin may work in an analogous way. Considering dissimilarity in structure, it is unlikely that requinomycin and levallorphan can share the same target molecule of the cell surface. Accordingly, these effects could be a common result of various changes in the conformation of the cell surface. 
